We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

1 hedge funds and large institutions have $40 invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

96% less capital invested

Capital invested by funds: $1K → $40 (-$960)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OPTFSNA
Old Point Trust & Financial Services N A
Virginia
+$40

Top Sellers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
OPTFSNA
1
Old Point Trust & Financial Services N A
Virginia
$40 +$40 +44 New
BTI
2
Blue Trust Inc
Georgia
– -$1K -916 Closed

FRTX Hedge Fund Activity: Q1 2024 in Review

1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2024, worth a combined $40 — down 96% from $1K a quarter earlier.

Fund positioning in FRTX was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Old Point Trust & Financial Services N A, opening a new position worth an estimated $40. The largest seller was Blue Trust Inc, exiting entirely with an estimated $1K sold.

  • 1 institutional investor held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $40 of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2024, down 96% quarter-over-quarter.
  • 1 fund opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of 0 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2024 was Old Point Trust & Financial Services N A, an estimated $40 added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2024 was Blue Trust Inc, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2024.